Immuneed Company
Immuneed is developing a new generation of prostate cancer vaccines, based on activation of the body's own immune system.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Uppsala, Uppsala Lan, Sweden
Founded Date:
2014
Employees Number:
11-50
Funding Status:
Seed
Total Funding:
$1.3M
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Register and Claim Ownership